$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000095017023061148 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$200.4M	$184.0M	$114.0M
YoY Change	63.97%	61.41%	1.39%
Cost Of Revenue	$63.79M	$64.24M	$30.57M
YoY Change	92.98%	110.13%	8.01%
Gross Profit	$136.6M	$119.8M	$83.42M
YoY Change	53.21%	43.56%	-0.83%
Gross Profit Margin	68.17%	65.09%	73.18%
Selling, General & Admin	$132.3M	$122.1M	$74.78M
YoY Change	56.01%	63.25%	3.28%
% of Gross Profit	96.82%	101.94%	89.64%
Research & Development	$18.94M	$18.56M	$11.94M
YoY Change	44.02%	55.4%	-3.37%
% of Gross Profit	13.86%	15.5%	14.32%
Depreciation & Amortization	$13.97M	$13.09M	$7.570M
YoY Change	88.24%	72.97%	5.86%
% of Gross Profit	10.22%	10.93%	9.07%
Operating Expenses	$151.2M	$140.6M	$86.73M
YoY Change	51.19%	62.17%	2.71%
Operating Profit	-$14.60M	-$24.45M	-$5.787M
YoY Change	34.59%	322.48%	1748.88%
Interest Expense	-$4.500M	-$1.576M	-$277.0K
YoY Change	1865.07%	468.95%	-36.03%
% of Operating Profit
Other Income/Expense, Net	$766.0K	-$2.360M	-$3.308M
YoY Change	-82.13%	-28.66%	84.91%
Pretax Income	-$22.05M	-$28.39M	-$9.372M
YoY Change	215.57%	202.87%	269.7%
Income Tax	$125.0K	$472.0K	$1.344M
% Of Pretax Income
Net Earnings	-$22.17M	-$28.86M	-$10.72M
YoY Change	213.99%	169.29%	393.6%
Net Earnings / Revenue	-11.06%	-15.68%	-9.4%
Basic Earnings Per Share		-$0.77	-$0.53
Diluted Earnings Per Share	-$0.59	-$0.77	-$0.53
COMMON SHARES
Basic Shares Outstanding	36.76M	36.74M	20.00M
Diluted Shares Outstanding		37.25K	20.09K

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.11M	$33.66M	$51.66M
YoY Change	-34.7%	-34.84%	-37.54%
Cash & Equivalents	$33.11M	$33.66M	$51.66M
Short-Term Investments
Other Short-Term Assets	$37.07M	$24.17M	$19.33M
YoY Change	66.37%	25.07%	-18.98%
Inventory	$222.2M	$221.7M	$100.3M
Prepaid Expenses
Receivables	$128.1M	$114.1M	$75.63M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$420.4M	$393.7M	$246.9M
YoY Change	64.24%	59.46%	-5.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$159.1M	$152.7M	$57.82M
YoY Change	173.16%	164.08%	-7.27%
Goodwill	$194.9M	$194.8M	$71.32M
YoY Change	173.33%	173.1%
Intangibles	$117.5M	$121.0M	$47.51M
YoY Change	147.93%	154.71%
Long-Term Investments
YoY Change
Other Assets	$33.39M	$43.48M	$24.57M
YoY Change	29.89%	76.95%	-35.3%
Total Long-Term Assets	$504.9M	$512.0M	$202.8M
YoY Change	149.15%	152.49%	-15.58%
TOTAL ASSETS
Total Short-Term Assets	$420.4M	$393.7M	$246.9M
Total Long-Term Assets	$504.9M	$512.0M	$202.8M
Total Assets	$925.3M	$905.7M	$449.7M
YoY Change	101.76%	101.41%	-10.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$58.36M	$53.26M	$28.00M
YoY Change	111.45%	90.2%	44.07%
Accrued Expenses	$12.19M	$3.259M	$1.503M
YoY Change	26.82%	116.83%	-24.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.250M	$693.0K	$638.0K
YoY Change	91.72%	8.62%	-75.18%
Total Short-Term Liabilities	$165.2M	$152.5M	$77.65M
YoY Change	97.58%	96.44%	-2.94%
LONG-TERM LIABILITIES
Long-Term Debt	$93.11M	$70.00M	$19.41M
YoY Change	383.95%	260.69%	-3.18%
Other Long-Term Liabilities	$49.72M	$48.92M	$19.07M
YoY Change	163.0%	156.6%	-46.31%
Total Long-Term Liabilities	$142.8M	$118.9M	$19.07M
YoY Change	655.47%	523.75%	-65.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$165.2M	$152.5M	$77.65M
Total Long-Term Liabilities	$142.8M	$118.9M	$19.07M
Total Liabilities	$326.6M	$290.2M	$116.1M
YoY Change	168.2%	149.89%	-14.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.1M	-$128.0M	$8.313M
YoY Change	-12101.92%	-1639.4%
Common Stock	$750.2M	$745.3M	$330.4M
YoY Change	122.61%	125.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$598.7M	$615.5M	$333.5M
YoY Change
Total Liabilities & Shareholders Equity	$925.3M	$905.7M	$449.7M
YoY Change	101.76%	101.41%	-10.14%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$22.17M	-$28.86M	-$10.72M
YoY Change	213.99%	169.29%	393.6%
Depreciation, Depletion And Amortization	$13.97M	$13.09M	$7.570M
YoY Change	88.24%	72.97%	5.86%
Cash From Operating Activities	-$6.694M	$441.0K	-$1.264M
YoY Change	-385.09%	-134.89%	-119.65%
INVESTING ACTIVITIES
Capital Expenditures	$15.05M	$22.30M	-$5.557M
YoY Change	106.94%	-501.24%	31.09%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$19.00K	$84.00K
YoY Change	-100.0%	-77.38%
Cash From Investing Activities	-$15.05M	-$22.38M	-$5.473M
YoY Change	155.14%	308.88%	29.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.28M	18.24M	-252.0K
YoY Change	1587.58%	-7338.89%	-129.47%
NET CHANGE
Cash From Operating Activities	-6.694M	441.0K	-1.264M
Cash From Investing Activities	-15.05M	-22.38M	-5.473M
Cash From Financing Activities	25.28M	18.24M	-252.0K
Net Change In Cash	3.533M	-3.695M	-6.989M
YoY Change	-272.01%	-47.13%	-329.3%
FREE CASH FLOW
Cash From Operating Activities	-$6.694M	$441.0K	-$1.264M
Capital Expenditures	$15.05M	$22.30M	-$5.557M
Free Cash Flow	-$21.75M	-$21.86M	$4.293M
YoY Change	341.47%	-609.11%	-59.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Central Index Key EntityCentralIndexKey	0000884624
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-19961
	dei	Entity Registrant Name EntityRegistrantName	ORTHOFIX MEDICAL INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1340767
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3451 Plano Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75056
	dei	City Area Code CityAreaCode	214
	dei	Local Phone Number LocalPhoneNumber	937-2000
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36756607
	dei	Security12b Title Security12bTitle	Common stock, $0.10 par value per share
	dei	Trading Symbol TradingSymbol	OFIX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33663000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50700000
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7090000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6419000
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	114118000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82857000
CY2023Q3	us-gaap	Inventory Net InventoryNet	221745000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1376000
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	615483000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	336860000
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	905652000
CY2022Q4	us-gaap	Inventory Net InventoryNet	100150000
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24170000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22283000
CY2023Q3	us-gaap	Assets Current AssetsCurrent	393696000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	255990000
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	152689000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58229000
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	121021000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47388000
CY2023Q3	us-gaap	Goodwill Goodwill	194767000
CY2022Q4	us-gaap	Goodwill Goodwill	71317000
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43479000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25705000
CY2023Q3	us-gaap	Assets Assets	905652000
CY2022Q4	us-gaap	Assets Assets	458629000
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	53261000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	27598000
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	693000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	652000
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	98576000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	55374000
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	152530000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83624000
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	70000000
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18715000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19239000
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48924000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18906000
CY2023Q3	us-gaap	Liabilities Liabilities	290169000
CY2022Q4	us-gaap	Liabilities Liabilities	121769000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36750000
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36750000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20162000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20162000
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3675000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2016000
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	741638000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	334969000
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127970000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1251000
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1860000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	458629000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184006000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113996000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	546226000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338484000
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	64243000
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30573000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	196583000
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	90491000
CY2023Q3	us-gaap	Gross Profit GrossProfit	119763000
CY2022Q3	us-gaap	Gross Profit GrossProfit	83423000
	us-gaap	Gross Profit GrossProfit	349643000
	us-gaap	Gross Profit GrossProfit	247993000
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	94947000
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	55461000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	287987000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	169486000
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27136000
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19322000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110124000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54496000
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18559000
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11943000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61290000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35913000
CY2023Q3	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	3570000
CY2022Q3	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	2484000
	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	11037000
	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	-9678000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-24449000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5787000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-120795000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2224000
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1576000
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-277000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4131000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1059000
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2360000
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3308000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1704000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7436000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28385000
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9372000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-126630000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10719000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1344000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2591000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1968000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-28857000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10716000
	us-gaap	Net Income Loss NetIncomeLoss	-129221000
	us-gaap	Net Income Loss NetIncomeLoss	-12687000
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37249
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20091
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36588
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20007
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37249
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20091
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36588
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20007
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-310000
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-236000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	8000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-749000
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-1442000
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-2105000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-492000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-4413000
CY2023Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-1752000
CY2022Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-2341000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-484000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-5162000
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1752000
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2341000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-484000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5162000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30609000
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13057000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-129705000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17849000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	336860000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-60938000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	430000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13020000
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	376745000
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-1958000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	664159000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-39426000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	838000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13246000
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1168000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	639985000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-28857000
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1752000
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6274000
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-167000
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	615483000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	336934000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4460000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1162000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4332000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-69000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	335575000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2489000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1659000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4460000
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1081000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	341946000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10716000
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2341000
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4729000
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-79000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	333539000
	us-gaap	Net Income Loss NetIncomeLoss	-129221000
	us-gaap	Net Income Loss NetIncomeLoss	-12687000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39094000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21598000
	ofix	Inventory Reserve Expenses InventoryReserveExpenses	24013000
	ofix	Inventory Reserve Expenses InventoryReserveExpenses	9856000
	ofix	Amortization Of Inventory Fair Value Step Up AmortizationOfInventoryFairValueStepUp	29006000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	4506000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	2321000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	905000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1713000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1148000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21000
	us-gaap	Share Based Compensation ShareBasedCompensation	32540000
	us-gaap	Share Based Compensation ShareBasedCompensation	13521000
	ofix	Change In Valuation Of Investment Securities ChangeInValuationOfInvestmentSecurities	82000
	ofix	Change In Valuation Of Investment Securities ChangeInValuationOfInvestmentSecurities	-254000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2100000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-17200000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-673000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1124000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2912000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48164000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29875000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-925000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-16000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4244000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3955000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-20000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4571000
	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	-4791000
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-562000
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-808000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39059000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13886000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45695000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16159000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1302000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1101000
	ofix	Contingent Consideration Payments Related To Asset Acquisitions ContingentConsiderationPaymentsRelatedToAssetAcquisitions	1500000
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	29419000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	500000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-126000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18078000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18634000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2377000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2400000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3334000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1467000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	483000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2441000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	70000000
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	26899000
	ofix	Contingent Consideration Milestone Payment ContingentConsiderationMilestonePayment	920000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-699000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-68000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40042000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1576000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	58000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2091000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17037000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36187000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50700000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	87847000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33663000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	51660000
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	2000000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2200000
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0.4163
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	184000000
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	181100000
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	546200000
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	512600000
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-21200000
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-32500000
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-96500000
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-102400000
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26422000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	17035000
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	54631000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	19243000
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	140692000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	63872000
CY2023Q3	us-gaap	Inventory Net InventoryNet	221745000
CY2022Q4	us-gaap	Inventory Net InventoryNet	100150000
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19765000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6788000
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16599000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17360000
CY2023Q3	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	36364000
CY2022Q4	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	24148000
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3259000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1638000
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	693000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	652000
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17171000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5376000
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18715000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19239000
CY2023Q3	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	39838000
CY2022Q4	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	26905000
	us-gaap	Operating Lease Payments OperatingLeasePayments	5538000
	us-gaap	Operating Lease Payments OperatingLeasePayments	3001000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	643000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	665000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	483000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2441000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15771000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5429000
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	26900000
CY2023Q1	ofix	Prepayment Premium PrepaymentPremium	600000
CY2023Q3	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	200000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	800000
CY2022Q3	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	300000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	900000
CY2023Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	7000000
CY2022Q3	ofix	Marketing Service Fees MarketingServiceFees	13511000
	ofix	Marketing Service Fees MarketingServiceFees	39234000
	ofix	Marketing Service Fees MarketingServiceFees	41832000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184006000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113996000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	546226000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184006000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113996000
CY2023Q3	ofix	Percentage Of Reported Increase Decrease PercentageOfReportedIncreaseDecrease	0.614
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	546226000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338484000
	ofix	Percentage Of Reported Increase Decrease PercentageOfReportedIncreaseDecrease	0.614
CY2023Q3	ofix	Revenue From Product Sales RevenueFromProductSales	170666000
CY2022Q3	ofix	Revenue From Product Sales RevenueFromProductSales	100485000
	ofix	Revenue From Product Sales RevenueFromProductSales	506992000
	ofix	Revenue From Product Sales RevenueFromProductSales	296652000
CY2023Q3	ofix	Marketing Service Fees MarketingServiceFees	13340000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338484000
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7015000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5589000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6419000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4944000
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	137000
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	415000
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	574000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	905000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1713000
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	214000
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	334000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	236000
CY2023Q3	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	126000
CY2022Q3	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	225000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	37000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	473000
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7090000
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5948000
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7090000
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5948000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2023Q3	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	13521000
CY2022Q3	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	14255000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	26644000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	32787000
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1576000
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-277000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4131000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1059000
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13097000
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7570000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39094000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21598000
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6274000
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4729000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32540000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13521000
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1909000
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3253000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1057000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7486000
CY2023Q3	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	5416000
	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	34362000
CY2023Q3	ofix	Strategic Investments StrategicInvestments	913000
CY2022Q3	ofix	Strategic Investments StrategicInvestments	3390000
	ofix	Strategic Investments StrategicInvestments	1883000
	ofix	Strategic Investments StrategicInvestments	6184000
CY2023Q3	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	7122000
CY2022Q3	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	419000
	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	26907000
	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	-15795000
CY2023Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	3851000
CY2022Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	125000
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	5611000
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	466000
CY2023Q3	ofix	Medical Device Regulation MedicalDeviceRegulation	1840000
CY2022Q3	ofix	Medical Device Regulation MedicalDeviceRegulation	2590000
	ofix	Medical Device Regulation MedicalDeviceRegulation	7519000
	ofix	Medical Device Regulation MedicalDeviceRegulation	6883000
CY2022Q3	ofix	Business Interruption Covid19 BusinessInterruptionCovid19	1215000
	ofix	Business Interruption Covid19 BusinessInterruptionCovid19	1874000
CY2023Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-92000
CY2022Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	59000
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	170000
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	230000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28385000
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9372000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-126630000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10719000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184006000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113996000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	546226000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338484000
CY2023Q3	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	4370000
CY2022Q3	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	2070000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	13137000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	6122000
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-800000
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-986000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2100000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-17200000
CY2022Q3	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1400000
	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1400000
CY2023Q3	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	3570000
CY2022Q3	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	2484000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-11037000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-9678000
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6274000
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4729000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32540000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13521000
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6274000
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4729000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32540000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13521000
CY2023Q3	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	16411
CY2022Q3	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	7057
	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	500000
	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	200000
CY2023Q3	ofix	Recognized Benefit From Termination Of Employees RecognizedBenefitFromTerminationOfEmployees	1100000
	ofix	Recognized Benefit From Termination Of Employees RecognizedBenefitFromTerminationOfEmployees	100000
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.017
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.143
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.184
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37249
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20091
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36588
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20007
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37249
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20091
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36588
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20007
CY2023Q3	ofix	Percentage Of Market Capitalization Decreased Due To Termination PercentageOfMarketCapitalizationDecreasedDueToTermination	0.30
CY2022Q4	us-gaap	Goodwill Goodwill	71317000
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	123450000
CY2023Q3	us-gaap	Goodwill Goodwill	194767000
	ecd	Trd Arr Ind Title TrdArrIndTitle	directors or officers
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000950170-23-061148-index-headers.html	Edgar Link	pending
0000950170-23-061148-index.html	Edgar Link	pending
0000950170-23-061148.txt	Edgar Link	pending
0000950170-23-061148-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img221715532_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ofix-20230930.htm	Edgar Link	pending
ofix-20230930.xsd	Edgar Link	pending
ofix-ex10_1.htm	Edgar Link	pending
ofix-ex10_2.htm	Edgar Link	pending
ofix-ex10_3.htm	Edgar Link	pending
ofix-ex10_4.htm	Edgar Link	pending
ofix-ex31_1.htm	Edgar Link	pending
ofix-ex31_2.htm	Edgar Link	pending
ofix-ex32_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
ofix-20230930_def.xml	Edgar Link	unprocessable
ofix-20230930_cal.xml	Edgar Link	unprocessable
ofix-20230930_lab.xml	Edgar Link	unprocessable
ofix-20230930_pre.xml	Edgar Link	unprocessable
ofix-20230930_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2023 Q4 Form 10-Q Financial Statement

#000095017023061148 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2023 Q4 Form 10-Q Financial Statement

#000095017023061148 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix